Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.17 -0.12 (-9.30%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Interest & Investment Income (2013 - 2026)

Updated

Aldeyra Therapeutics' Interest & Investment Income came in at $400,257 for Q2 2026, down 54.1% from $872,038 a year earlier and down 28.9% from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Interest & Investment Income (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aldeyra Therapeutics reported Interest & Investment Income of $2.43 million, down 47.1% year-over-year; for FY2025, it was $3.32 million, down 46.3% from FY2024.

  • Interest & Investment Income carries a five-year compound annual growth rate of 62.6% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $6.19 million in FY2024 (-15.4%), $7.32 million in FY2023 (+211.7%), $2.35 million in FY2022 and $185,363 in FY2021 (-36.6%).
  • The Q2 2026 figure represents the lowest quarterly Interest & Investment Income since Q2 2022.
  • Year-over-year, Interest & Investment Income has declined for nine consecutive quarters, with an average decline of 42.0% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q3 2022 (growth of 993.0%), and the weakest in Q2 2026 (a decline of 54.1%).
  • Business Quant data shows ALDX's Interest & Investment Income at $562,977 (Q1 2026), $681,635 (Q4 2025) and $788,694 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Aldeyra Therapeutics 70.58 Mn 70.58 Mn - 400,257.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 400,257.00
Mar 31, 2026 562,977.00
Dec 31, 2025 681,635.00
Sep 30, 2025 788,694.00
Jun 30, 2025 872,038.00
Mar 31, 2025 981,487.00
Dec 31, 2024 1.24 Mn
Sep 30, 2024 1.50 Mn
Jun 30, 2024 1.64 Mn
Mar 31, 2024 1.81 Mn
Dec 31, 2023 1.86 Mn
Sep 30, 2023 1.90 Mn
Jun 30, 2023 1.88 Mn
Mar 31, 2023 1.68 Mn
Dec 31, 2022 1.26 Mn
Sep 30, 2022 648,242.00
Jun 30, 2022 344,378.00
Mar 31, 2022 101,382.00
Dec 31, 2021 62,631.00
Sep 30, 2021 59,306.00
API Access

Aldeyra Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ALDX&period=max&api_key=YOUR_API_KEY